# TRD-021 RISK Review

## Verdict

`pass`

TRD-021 adds protected-loop diagnostics while preserving Gate 0 Research Only.

## Scope Reviewed

- `packages/core/src/local-protected-loop-diagnostic.ts`
- `packages/core/tests/local-protected-loop-diagnostic.test.ts`

## Risk Findings

No blocking findings.

Passed:

- Diagnostic objects preserve the financial gate as `G0_RESEARCH`.
- Diagnostic objects preserve `research_only` scope.
- Diagnostics combine local evidence-loop state without changing strategy state.
- Diagnostics do not infer approval, advice, readiness, forecasts, or strategy claims.
- Blocked and needs-review states remain descriptive diagnostic statuses only.
- No paper execution path, live execution path, broker integration, autonomous execution, AI
  prediction, strategy promotion, risk-limit increase, or strategy performance claim was introduced.

## Residual Risk

The diagnostic object is not an approval workflow, UI workflow, report export format, or external
sharing policy. Human operator judgment remains outside this local aggregate.

## Recommended Next Agent

`ORCHESTRATOR`
